A Radical Treatment for Insulin Pricing

A Radical Treatment for Insulin PricingA private, nonprofit company recently announced that it intends to bypass the traditional supply chain and sell interchangeable biosimilar insulin products at substantially reduced prices.

Saved in:

Bibliographic Details
Published in:	The New England journal of medicine Vol. 386; no. 23; pp. 2157 - 2159
Main Author:	Dafny, Leemore S.
Format:	Journal Article
Language:	English
Published:	United States Massachusetts Medical Society 09.06.2022
Subjects:	and the FDA Biological products Brand names Cost control Cost of Health Care Devices Diabetes Drug stores Drugs Endocrinology Generic drugs Health Policy Insulin Patients Pharmaceutical industry Pharmacy Prices Profits Rebates Supply chains United States > US Health Policy Medicine and Business Drug and Device Safety
ISSN:	0028-4793, 1533-4406, 1533-4406
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!